CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020
July 30, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Resumes CB4211 Phase 1b Clinical Trial
July 07, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at Sachs Novel Coronavirus Investment Forum
July 06, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering
June 30, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Founder Dr. Nir Barzilai’s New Book “AGE LATER” Reveals that Aging Can Be Seen as a Preventable Disease
June 17, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020
June 02, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference
May 27, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Reports First Quarter 2020 Financial Results and Provides Business Update
May 14, 2020 16:02 ET
|
CohBar, Inc.
MENLO PARK, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role
May 13, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides
May 05, 2020 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...